Optimization of chondroitin production in E. coli using genome scale models

Abstract

E. coli was used to produce chondroitin both in silico and in vivo, marking the first use of genome-scale metabolic models to predict its production. Identified targets can guide future works towards more efficient hosts for chondroitin production.